On air · 2 of 3 networks
Vetter Pharma
- vetter-pharma.com
- DE
- 2,580 employees
Vetter Pharma’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 170. Watch Vetter Pharma with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 118 | Checked 30 Oct 2026 | See all 170 ads → | ||
| Meta | Running | 5 | Active ads on the Meta Ad Library, all countries | Checked 28 Oct 2026 | Collect them with the API → |
| Recently | 300+ | Ads on the Google Ads Transparency Center | Checked 14 Oct 2026 | Collect them with the API → |
Vetter Pharma has 118 live LinkedIn ads. Its Facebook page had 5 active ads on 28 Oct 2026, and we recorded 300+ Google ads on 14 Oct 2026.
Latest ads
- LINKEDIN · VIDEOSince 19 Oct 2026
Ready for first‑in‑human with your injectable molecule? Get practical guidance from our experts on how to navigate the critical transition from lab to clinic and successfully unlocking a new development phase for your products.
- LINKEDIN · IMAGESince 16 Oct 2026
Stability studies are critical to product quality, patient safety, and regulatory approval throughout the entire product lifecycle. Join our webcast to explore global regulatory requirements, effective strategies, and best practices for designing stability programs, from early development through commercial manufacturing.
- LINKEDIN · IMAGESince 16 Sept 2026
Ready for first‑in‑human with your injectable molecule? Get practical guidance from our experts on how to navigate the critical transition from lab to clinic and successfully unlocking a new development phase for your products.
- LINKEDIN · IMAGESince 16 Sept 2026
Our experts will share their best planning practices how to navigate this critical transition and successfully, unlocking a new development phase for your injectable product.
- LINKEDIN · IMAGESince 18 Jun 2026
Getting the green light to begin clinical development is a major milestone for any injectable molecule. It’s the time when an API becomes a human-ready drug product. It’s also the point at which drug owners trade benchtop exploration for market readiness rigor: well-controlled processes, cGMP requirements, regulatory expectations, and more. Preparing for these new priorities is an essential part of entering a Phase I clinical trial. In this webcast, clinical manufacturing experts who have supported over 150 companies and 300 compounds will share their best planning practices how to navigate this critical transition and successfully, unlocking a new development phase for your products. ➡️ Watch this on-demand version of our webcast to find out how you can make the transition from pre-clinical to clinical development as efficient and smooth as possible.
- LINKEDIN · IMAGESince 13 Apr 2026
Are you interested in LC–MS analytics and want to explore how it enables reliable, high‑quality testing throughout the entire lifecycle of oligonucleotide‑based injectables? 🔍 You will learn: ✅How LC–MS supports quality, safety, and compliance across the product lifecycle ✅Key considerations for developing robust, compliant LC-MS analytical methods ✅Best practice strategies to implement reliable and efficient workflows Register here to secure your spot!
6 of 170 adsSign up to see every Vetter Pharma ad, filter by format and date, and get alerts on new ones.
See all 170 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.